Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Old Ayala, Inc (AYLA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/24/2023 |
4
| aMoon Growth Fund Limited Partnership (10% Owner) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 2,991,473 shares
@ $0 |
|
| 01/23/2023 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 250 shares
@ $0
Disposed/sold 12,500 options to buy
@ $10.35, valued at
$129.4k
Disposed/sold 12,500 options to buy
@ $1.63, valued at
$20.4k
|
|
| 01/23/2023 |
4
| Maimon Yossi (CFO, Secretary and Treasurer) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 69,872 shares
@ $0
Disposed/sold 70,500 options to buy
@ $5.16, valued at
$363.8k
Disposed/sold 9,460 options to buy
@ $6.5, valued at
$61.5k
Disposed/sold 19,170 options to buy
@ $11.26, valued at
$215.9k
Disposed/sold 31,950 options to buy
@ $9.105, valued at
$290.9k
|
|
| 01/23/2023 |
4
| Spiegel Robert J. (Director) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 17,500 options to buy
@ $5.1, valued at
$89.3k
Disposed/sold 12,500 options to buy
@ $8.84, valued at
$110.5k
Disposed/sold 6,250 options to buy
@ $10.35, valued at
$64.7k
Disposed/sold 6,250 options to buy
@ $1.63, valued at
$10.2k
|
|
| 01/23/2023 |
4
| Gordon Gary B. (Chief Medical Officer) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 58,520 shares
@ $0
Disposed/sold 89,000 options to buy
@ $5.16, valued at
$459.2k
Disposed/sold 19,170 options to buy
@ $11.26, valued at
$215.9k
Disposed/sold 31,950 options to buy
@ $9.105, valued at
$290.9k
|
|
| 01/23/2023 |
4
| GOLDBERG MURRAY A (Director) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 17,500 options to buy
@ $5.1, valued at
$89.3k
Disposed/sold 12,500 options to buy
@ $8.84, valued at
$110.5k
Disposed/sold 6,250 options to buy
@ $10.35, valued at
$64.7k
Disposed/sold 6,250 options to buy
@ $1.63, valued at
$10.2k
|
|
| 01/23/2023 |
4
| Bisker-Leib Vered (Director) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 8,750 options to buy
@ $10.98, valued at
$96.1k
Disposed/sold 6,250 options to buy
@ $10.35, valued at
$64.7k
Disposed/sold 6,250 options to buy
@ $1.63, valued at
$10.2k
|
|
| 01/23/2023 |
4
| Mamluk Roni (President & CEO) has filed a Form 4 on Old Ayala, Inc|
Txns:
| Disposed/sold 265,345 shares
@ $0
Disposed/sold 47,299 options to buy
@ $15, valued at
$709.5k
Disposed/sold 76,680 options to buy
@ $11.26, valued at
$863.4k
Disposed/sold 127,800 options to buy
@ $9.105, valued at
$1.2M
|
|
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
4
| Gordon Gary B. (Chief Medical Officer) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 05/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Mamluk Roni (President & CEO) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 127,800 options
@ $9.105, valued at
$1.2M
|
|
| 01/05/2022 |
4
| Gordon Gary B. (Chief Medical Officer) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 31,950 options
@ $9.105, valued at
$290.9k
|
|
| 01/05/2022 |
4
| Maimon Yossi (CFO, Secretary & Treasurer) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 31,950 options
@ $9.105, valued at
$290.9k
|
|
| 06/14/2021 |
4
| Bisker-Leib Vered (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 6,250 options to buy
@ $10.35, valued at
$64.7k
|
|
| 06/14/2021 |
4
| Spiegel Robert J. (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 6,250 options to buy
@ $10.35, valued at
$64.7k
|
|
| 06/14/2021 |
4
| SIDRANSKY DAVID (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 12,500 options to buy
@ $10.35, valued at
$129.4k
|
|
| 06/14/2021 |
4
| GOLDBERG MURRAY A (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 6,250 options to buy
@ $10.35, valued at
$64.7k
|
|
| 06/14/2021 |
4
| Sone Todd (Director) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 6,250 options to buy
@ $10.35, valued at
$64.7k
|
|
| 03/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Mamluk Roni (President & CEO) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Sold 19,466 shares
@ $15.0279, valued at
$292.5k
Sold 1,406 shares
@ $15.0406, valued at
$21.1k
|
|
| 01/22/2021 |
4
| Gordon Gary B. (Chief Medical Officer) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Sold 3,000 shares
@ $15.0279, valued at
$45.1k
Exercised 3,000 options
@ $5.16, valued at
$15.5k
|
|
| 01/06/2021 |
4
| Maimon Yossi (CFO, Secretary & Treasurer) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 8,520 shares
@ $0
Granted 19,170 options
@ $11.26, valued at
$215.9k
|
|
| 01/06/2021 |
4
| Gordon Gary B. (Chief Medical Officer) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 8,520 shares
@ $0
Granted 19,170 options
@ $11.26, valued at
$215.9k
|
|
| 01/06/2021 |
4
| Mamluk Roni (President & CEO) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Granted 34,080 shares
@ $0
Granted 76,680 options
@ $11.26, valued at
$863.4k
|
|
| 08/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/14/2020 |
4
| Harel Insurance Co LTD (10% Owner) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Converted 307,692 shares
@ $0
Converted 211,757 shares
@ $0
Bought 50,000 shares
@ $15, valued at
$750k
Bought 500,000 shares
@ $15, valued at
$7.5M
Converted 307,692 options to buy
@ $0
Converted 211,757 options to buy
@ $0 |
|
| 05/14/2020 |
4
| Israel Biotech Fund I, L.P. (10% Owner) has filed a Form 4 on Ayala Pharmaceuticals, Inc.|
Txns:
| Converted 369,231 shares
@ $0
Converted 211,757 shares
@ $0
Bought 225,000 shares
@ $15, valued at
$3.4M
Converted 738,462 preferred shares
@ $0
Converted 423,514 preferred shares
@ $0 |
|
|
|
|